BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 382108)

  • 1. [Alternative complement pathway (author's transl)].
    Kazatchkine M; Nydegger U; Fearon DT
    Nouv Presse Med; 1979 Jun; 8(26):2187-94. PubMed ID: 382108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Alternative complement pathway].
    Jouvin MH; Kazatchkine M
    Sem Hop; 1984 May; 60(19):1371-8. PubMed ID: 6326330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The alternative complement pathway].
    Jouvin MH; Kazatchkine M
    Pathol Biol (Paris); 1983 Dec; 31(10):839-46. PubMed ID: 6230588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus.
    Whaley K; Schur PH; Ruddy S
    Clin Exp Immunol; 1979 Jun; 36(3):408-14. PubMed ID: 114347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins.
    Schreiber RD; Pangburn MK; Lesavre PH; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3948-52. PubMed ID: 279011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative pathway complement activation in rheumatoid arthritis.
    El-Ghobarey A; Whaley K
    J Rheumatol; 1980; 7(4):453-60. PubMed ID: 6158571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the alternative complement pathway.
    Fearon DT
    CRC Crit Rev Immunol; 1979 Nov; 1(1):1-32. PubMed ID: 162484
    [No Abstract]   [Full Text] [Related]  

  • 8. Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells.
    Pangburn MK; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1978 May; 75(5):2416-20. PubMed ID: 276881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes.
    Whaley K
    J Exp Med; 1980 Mar; 151(3):501-16. PubMed ID: 6444659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the properdin amplification loop in membranoproliferative and other forms of glomerulonephritis.
    Whaley K; Ward D; Ruddy S
    Clin Exp Immunol; 1979 Jan; 35(1):101-6. PubMed ID: 85507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activation of the alternative pathway of human complement (author's transl)].
    Kazatchkine M; Fischer E; Nydegger U
    Ann Immunol (Paris); 1982; 133C(2):181-8. PubMed ID: 7051949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular biology and chemistry of the alternative pathway of complement.
    Müller-Eberhard HJ; Schreiber RD
    Adv Immunol; 1980; 29():1-53. PubMed ID: 6158260
    [No Abstract]   [Full Text] [Related]  

  • 13. [Determination of the activity of the alternative pathway factor].
    Nakanishi I; Inai S
    Nihon Rinsho; 1979 Jun; Suppl():1451-3. PubMed ID: 490919
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products.
    Farries TC; Lachmann PJ; Harrison RA
    Biochem J; 1988 May; 252(1):47-54. PubMed ID: 3421908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solubilization of immune precipitates by six isolated alternative pathway proteins.
    Fujita T; Takata Y; Tamura N
    J Exp Med; 1981 Dec; 154(6):1743-51. PubMed ID: 6459396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of C5 convertase activity by properdin, factors B and H.
    Weiler JM
    Immunol Res; 1989; 8(4):305-15. PubMed ID: 2531781
    [No Abstract]   [Full Text] [Related]  

  • 17. Components of the alternative pathway of complement in otitis media with effusion.
    Parker MJ; Leopold DA; Stitzel AE; Welch TR; Weiner LB; Spitzer RE
    Otolaryngol Head Neck Surg; 1985 Oct; 93(5):607-11. PubMed ID: 2932669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and quantitation of the components of the alternative complement pathway.
    Minta JO; Gee AP
    Methods Enzymol; 1983; 93():375-408. PubMed ID: 6223199
    [No Abstract]   [Full Text] [Related]  

  • 19. The alternative pathway of complement.
    Pangburn MK; Müller-Eberhard HJ
    Springer Semin Immunopathol; 1984; 7(2-3):163-92. PubMed ID: 6238433
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of the interaction between properdin and factor B, components of the alternative-pathway C3 convertase of complement.
    Farries TC; Lachmann PJ; Harrison RA
    Biochem J; 1988 Aug; 253(3):667-75. PubMed ID: 3140783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.